• Expanded Access Programs
  • Imports (Unlicensed Medicines)
  • International Sales
  • Clinical Trial Supply
  • Sales to NGOs & Charities
  • Sexual Health Supplies
  • Bespoke Distribution
  • Durbin USA
  • About Us
  • News
  • Contact Us
  • Join our Mailing List

    Privacy: Our mailing list will only be used to send you relevant Durbin updates and information. Please click here to see our full Privacy Policy.

    Full Name
    Email Address


    Early Access Distribution of Dalfampridine

    20 September 2010

    Durbin PLC has been appointed to co-ordinate the early access programme for Dalfampridine, which has recently been licensed in the USA to improve walking in patients with Multiple Sclerosis.

    Durbin will be working with importers, hospitals and physicians across the globe to enable patients to access this treatment as quickly and easily as possible.

    Durbin is a leading global pharmaceutical supplier with unrivalled expertise in global distribution, compliance with international regulations and ethical partnerships. Founded over 45 years ago, Durbin has divisions in Clinical Trials Supply, Early Access Programmes, Sexual Health Supplies, Unlicensed Medicines, Charity and NGO Supply, and International Pharmaceutical Distribution.

    Leslie Morgan, CEO of Durbin comments;

    “We are pleased to be making this new medication available through an early access programme. Durbin is committed to improving the lives of patients, and our expertise and knowledge combined with our global reach, means that we can effectively help physicians and patients get access to Dalfampridine quickly.”

    For all enquiries, please contact Durbin on +44 (0)20 8869 6517 or email ampyra@durbin.co.uk

    Press Releases